(Q41248831)

28 September 2017

title

Increased statin prescribing does not lower pneumonia risk (English)

1 reference

28 September 2017

0 references

Linnea A Polgreen

1

1 reference

28 September 2017

Elizabeth A Cook

2

1 reference

28 September 2017

John M Brooks

3

1 reference

28 September 2017

Yuexin Tang

4

1 reference

28 September 2017

Philip M Polgreen

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

10 March 2015

1 reference

Clinical Infectious Diseases

28 September 2017

published in

1 reference

28 September 2017

volume

60

1 reference

28 September 2017

issue

12

1 reference

28 September 2017

page(s)

1760-1766

1 reference

Statins for the prevention and treatment of infections: a systematic review and meta-analysis

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

The effects of statins on mortality rates among bacteremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Prior statin use is associated with improved outcomes in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Effect of statin treatment on short term mortality after pneumonia episode: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins in candidemia: clinical outcomes from a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Association between statins and infections after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statin use and the risk of Clostridium difficile in academic medical centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Simvastatin protects against T cell immune dysfunction in abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins enhance formation of phagocyte extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins: panacea for sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Understanding the potential role of statins in pneumonia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statin use and risk of community acquired pneumonia in older people: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

The lesser known effects of statins: benefits on infectious outcomes may be explained by "healthy user" effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

What is the effect of area size when using local area practice style as an instrument?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins decrease the occurrence of venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statin use and reduced cancer-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Pandemic influenza: a potential role for statins in treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Risk for myopathy with statin therapy in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

Statin use and mortality within 180 days after bacteremia: A population-based cohort study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV190

21 January 2018

Identifiers

DOI

10.1093/CID/CIV190

1 reference

28 September 2017

1 reference